Daniel Gately has a background in microbiology and biotechnology, with experience in mRNA process development and manufacturing. Daniel has worked as a Scientist at Strand Therapeutics since December 2020 and held positions at bluebird bio and EMD Serono, Inc. with a focus on analytical methods for mRNA quality evaluation. Daniel also has experience in immunology research and laboratory analysis from internships at EMD Serono, Inc. and Analytical Testing Laboratory.
Current role